EnglishD'ARCA, Domenico
Risultati 1 - 20 di 36 (tempo di esecuzione: 0.0 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies | 2018 | Davalli, Pierpaola; Marverti, Gaetano; Lauriola, Angela; D’Arca, Domenico |
| 2 | Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study. | 2003 | S. Bettuzzi ; M. Scaltriti; A. Caporali; M. Brausi ; D. D'Arca; S. Astancolle; P. Davalli; A. Corti |
| 3 | Spermidine/spermine N1-acetyltransferase transient over-expression restores sensitivity of resistant human ovarian cancer cells to N1,N12-bis(ethyl)spermine and to cisplatin | 2005 | MARVERTI G; MONTI M.G; PEGG A.E; MCCLOSKEY D.E; BETTUZZI S; LIGABUE A; CAPORALI A; D. D'ARCA; MORUZZI M.S |
| 4 | ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases | 2016 | Davalli, P; Mitic, T; Caporali, A; Lauriola, A; D'Arca, D |
| 5 | Repurposing of drugs targeting yap-tead functions | 2018 | Elisi, Gian Marco; Santucci, Matteo; D’Arca, Domenico; Lauriola, Angela; Marverti, Gaetano; Losi, Lorena; Scalvini, Laura; Bolognesi, Maria Laura; Mor, Marco; Costi, Maria Paola |
| 6 | PTEROATE-PEPTIDE BIOCONJUGATE TARGETING THE FOLATE RECEPTOR IN HUMAN OVARIAN CANCER CELL LINES: TRANSPORT AND MECHANISM OF ACTION. | 2013 | Costi, Maria Paola; Marverti, Gaetano; Pirondi, Silvia; Martello, Andrea; D'Arca, Domenico; Pela', Michela; Guerrini, R.; Marraccini, Chiara |
| 7 | Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer | 2018 | Severi, Leda; Losi, Lorena; Fonda, Sergio; Taddia, Laura; Gozzi, Gaia; Marverti, Gaetano; Magni, Fulvio; Chinello, Clizia; Stella, Martina; Sheouli, Jalid; Braicu, Elena I.; Genovese, Filippo; Lauriola, Angela; Marraccini, Chiara; Gualandi, Alessandra; D'Arca, Domenico; Ferrari, Stefania; Costi, Maria P. |
| 8 | Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor | 2009 | D. D'Arca; J. Lenoir; B. Wildemore; F. Gottardo; E. Bragantini; D. Shupp-Byrne; N. Zanesi; M. Fassan; C.M. Croce; L.G. Gomella; R. Baffa |
| 9 | Prevention of bladder cancer in the FHIT knock-out mouse model with rofecoxib, a COX-2 inhibitor | 2006 | Lenoir, J; D’Arca, D; Gottardo, F; Bragantini, E; Wildemore, B; Shupp-Byrne, D; Zanesi, N; Croce, Cm; Gomella, Lg; Baffa, R |
| 10 | pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells | 2018 | Sacchetti, Francesca; Marverti, Gaetano; D’Arca, Domenico; Severi, Leda; Maretti, Eleonora; Iannuccelli, Valentina; Pacifico, Salvatore; Ponterini, Glauco; Costi, Maria Paola; Leo, Eliana |
| 11 | pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line | 2015 | Sacchetti, Francesca; Marraccini, Chiara; D'Arca, Domenico; Pinetti, Diego.; Genovese, Filippo; Maretti, Eleonora; Iannuccelli, Valentina; Costi, Maria Paola; Leo, Eliana |
| 12 | Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth | 2014 | M. Pelà; P. Saxena; R. Luciani; M. Santucci; S. Ferrari; G. Marverti; C. Marraccini; A. Martello; S. Pirondi; F. Genovese; S. Salvadori; D. D’Arca; G. Ponterini; M.P. Costi; R. Guerrini |
| 13 | Nuclear traslocation of a truncated clusterin isoform is associated to induction of anoikis in SV40-immortalized human prostate epithelial cells. | 2003 | CACCAMO, A.E.; SCALTRITI, M.; CAPORALI, A.; D'ARCA, D.; SCORCIONI, F.; CANDIANO, G.; MANGIOLA, M.; BETTUZZI, S. ; |
| 14 | The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. | 2009 | Zhao X; D' Arca D; Lim WK; Brahmachary M; Carro MS; Ludwig T; Cardo CC; Guillemot F; Aldape K; Califano A; Iavarone A; Lasorella A. |
| 15 | MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer | 2009 | VECCHIONE A; FASSAN M; ANESTI V; MORRIONE A; GOLDONI S; BALDASSARRE G; BYRNE D; D. D'ARCA; PALAZZO JP; LLOYD J; SCORRANO L; GOMELLA LG; IOZZO RV; BAFFA R |
| 16 | Mitostatin, a novel mitochondrial protein, that acts as a tumor suppressor in prostate cancer cells | 2008 | M., Fassan; D'Arca, Domenico; J., Letko; A., Vecchione; A., Morrione; M., Gardiman; P., Mccue; B., Wildemore; M., Rugge; D., Shupp Byrne; L. G., Gomella; R. V., Iozzo; R., Baffa |
| 17 | MITOSTATIN, A NOVEL MITOCHONDRIAL PROTEIN, THAT ACTS AS A TUMOR SUPPRESSOR IN PROSTATE CANCER CELLS | 2008 | Fassan, Matteo; D'Arca, Domenico; Letko, Juraj; Vecchione, Andrea; Morrione, Andrea; Gardiman, Marina; Mccue, Peter; Wildemore, Bernadette; Rugge, Massimo; Shupp Byrne, Dolores; Gomella, Leonard G; Iozzo, Renato V; Baffa, Raffaele |
| 18 | Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells | 2011 | M.Fassan; D. D'Arca; J. Letko; A. Vecchione; M. P. Gardiman; P. McCue; B. Wildemore; M. Rugge; D. Shupp-Byrne; L. G. Gomella; A. Morrione; R. V. Iozzo; R. Baffa |
| 19 | Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides | 2014 | F. Genovese; A. Gualandi; L. Taddia; G. Marverti; S. Pirondi; C. Marraccini; P. Perco; M. Pelà; R. Guerrini; M.R. Amoroso; F. Esposito; A. Martello; G. Ponterini; D. D’Arca; M.P. Costi |
| 20 | The key role of Mitostatin in the maintenance of genome stability | 2017 | Lauriola, Angela; Caporali, Andrea; Mai, Sabine; D'Arca, Domenico |
Nome completo:
D'ARCA, Domenico
Copyright © 2019